LONDON (Alliance News) - GlaxoSmithKline PLC Monday said a person connected with Chairman of Research and Development, Moncef Slaoui, benefitted from a revaluation of the cash element of the notional investment held within the company's 401K plan, gaining American Depositary Shares at a price of USD52.05 per ADS Friday as a result.
Details of the transaction are as follows.
Director/PDMR
|
Number of ADSs |
Connected Person |
Number of ADSs | ||
Dr M Slaoui
|
- |
Dr K Slaoui |
4 | ||
Shares in the global healthcare company closed at 1620.52 pence down 1.00% Monday.
By Arvind Bhunjun; arvindbhunjun@alliancenews.com; @arvindbhunjun
Copyright © 2013 Alliance News Limited. All Rights Reserved.
Glaxosmithkline (GSK)